Video

Dr. Davis on the Influence of Racial Constructs and Genetic Ancestry in TNBC

Melissa B. Davis, PhD, discusses the influence of racial constructs and genetic ancestry in triple negative breast cancer.

Melissa B. Davis, PhD, assistant professor, Cell and Developmental Biology, Department of Surgery, scientific director, International Center for the Study of Breast Cancer Subtypes, Weill Cornell Medical College, discusses the influence of racial constructs and genetic ancestry in triple negative breast cancer (TNBC).

Worse outcomes in patients with TNBC have been associated with social constructs, Davis says. However, these are not the only factors that can contribute to outcomes for these patients. Genetic lineage can also correlate with social constructs to contribute to outcomes, Davis adds. For example, in African American patients, West African ancestry is associated with TNBC subtypes, Davis explains.

When comparing genetic ancestry vs race, it was found that genetic pathways for comorbidities, such as diabetes, inflammation, and metabolic disorders, were imprinted on the tumor cells in patients in the race group, Davis continues. These findings help create the link between factors that are genetically driven from ancestry and genetically driven because of a lived experience, Davis concludes.

Related Videos
Alastair Thompson, BSc, MBChB, MD, FRCS
C. Ola Landgren, MD, PhD
Sara M. Tolaney, MD, MPH
Adam M. Brufsky, MD, PhD, FACP
Justin M. Watts, MD
Sara M. Tolaney, MD, MPH
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Chirag Shah, MD
Jason A. Mouabbi, MD